Literature DB >> 11267498

Role of interleukin-12 in acute graft-versus-host disease(1).

L A Welniak1, B R Blazar, R H Wiltrout, M R Anver, W J Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267498     DOI： 10.1016/s0041-1345(00)02666-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

2.  Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.

Authors:  Lia Perez; Hugo Fernandez; Pedro Horna; Marcie Riches; Frederick Locke; Teresa Field; John Powers; Eva Sahakian; Alejandro Villagra; Asmita Mishra; Brian Betts; Mohamed Kharfan-Dabaja; Francisca Beato; Leonel Ochoa-Bayona; Joseph Pidala; Claudio Anasetti
Journal:  Bone Marrow Transplant       Date:  2018-04-18       Impact factor: 5.483

3.  Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation.

Authors:  Lisbeth A Welniak; Dmitry V Kuprash; Alexei V Tumanov; Angela Panoskaltsis-Mortari; Bruce R Blazar; Kai Sun; Sergei A Nedospasov; William J Murphy
Journal:  Blood       Date:  2005-09-13       Impact factor: 22.113

4.  Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib.

Authors:  Kai Sun; Lisbeth A Welniak; Angela Panoskaltsis-Mortari; Matthew J O'Shaughnessy; Haiyan Liu; Isabel Barao; William Riordan; Raquel Sitcheran; Christian Wysocki; Jonathan S Serody; Bruce R Blazar; Thomas J Sayers; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

5.  Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis.

Authors:  P Reddy; T Teshima; M Kukuruga; R Ordemann; C Liu; K Lowler; J L Ferrara
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.